The PPV-06 vaccine was safe, immunogenic, and linked with functional improvement at 42 weeks in a phase 1 trial of inflammatory knee osteoarthritis.

An end-of-the-year slowdown has not been witnessed by the biopharma industry yet, and certainly not in the biotech deals ...

OSE Immunotherapeutics Unveils 2026–2028 Strategic Plan With Four Opportunities for Value CreationCompletion of Tedopi’s phase 3 in Non-Small ...

Harmonic , the worldwide leader in virtualized broadband and video delivery solutions, today announced it has received a binding offer from MediaKind, a global leader in cloud-based video streaming ...

Kite, a Gilead Company , presented a new analysis today demonstrating that second-line Yescarta® (axicabtagene ciloleucel) therapy offers consistent benefits in patients with relapsed/refractory large ...

From education access to medical breakthroughs and environmental conservation, these stories showcase inspiring progress ...

NANTES, France, December 8th, 2025 - 7:30am CET - OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) today announced ...

What is a common phrase bestowed upon tombstones, in condolence messages, and amongst social media posts following the death ...

Of all the rich and varied parts of the French language, it is perhaps swearing that poses the biggest translation problem.

This Tuesday French MPs are taking part in a vote on a crucial part of the 2026 budget. One measure that has already been ruled out is a major increase in inheritance tax. Yet as Mediapart here ...